FRNM
FRNM clinical trials: Freenome, Inc.
Every trial on ClinicalTrials.gov where Freenome, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 5
- Trials linked
- 5
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
FRNM on the catalyst calendar · FRNM registry changes
- Primary completion Feb 29, 2024ActualNo phase registeredNCT04369053Prevention of Colorectal Cancer Through Multiomics Blood TestingFreenome Holdings Inc. · Colon CancerCompletedFRNMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 24, 2024ActualNo phase registeredNCT05254834The Vallania Study: A Case Control Study for the Development of Multiomics Blood Tests for Cancer ScreeningFreenome Holdings Inc. · CancerCompletedFRNMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 15, 2026Sponsor estimateNo phase registeredNCT06122077Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer ScreeningFreenome Holdings Inc. · Lung Cancer DiagnosisRecruitingFRNMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 20, 2023ActualNo phase registeredNCT05516927The Sanderson Study: A Case Control Study for the Development of Multiomics Blood Tests for Cancer ScreeningFreenome Holdings Inc. · Newly-diagnosed CancersCompletedFRNMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 25, 2019ActualNo phase registeredNCT03688906AI-EMERGE: Development and Validation of a Multi-analyte, Blood-based Colorectal Cancer Screening TestFreenome Holdings Inc. · Colo-rectal CancerCompletedFRNMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 5 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner